Molecular structure and affinity to 5-HT1A receptor of chlorophenyl(piperazinylalkyl)phthalimides

被引：0
|
作者：
Chumakov, YM [1 ]
Simonov, YA
Soboleva, SG
Sava, VM
Andronati, SA
Gdaniec, M
Bocelli, G
机构：
[1] Moldavian Acad Sci, Inst Appl Phys, Kishinev 2028, Moldova
[2] Ukrainian Acad Sci, AV Bogatsky Physicochem Inst, Odessa, Ukraine
[3] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
[4] CNR, Ctr Studio Strutturist Diffrattometr, I-43100 Parma, Italy
来源：
SUPRAMOLECULAR CHEMISTRY | 2000年 / 12卷 / 02期
关键词：
psychotropic agents; chlorophenyl(piperazinylalkyl)phtalimides; serotonin receptors; affinity; pharmacophore;
D O I：
10.1080/10610270008027456
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
X-ray crystallography, quantum-chemical calculations and conformational analysis have been employed to study chlorophenyl(piperazinylalkyl)phthalimides, potential ligands of 5-HT1A receptor. The molecular recognition of investigated compounds by 5-HT(1A)serotonin receptor has been estimated according to their ability to inhibit the [(3)H8]-DPAT binding. The model for 5-HT1A pharmacophore has been proposed based on crystal structures of N-(aryl)piperazinyl - alkylphthalimides.
引用
收藏
页码：225 / 227
页数：3
相关论文
共 50 条
  • [31] 5-HT1A RECEPTOR LIGANDS AS POTENTIAL ANTIDEPRESSANTS
    Wrobel, Martyna Z.
    Marciniak, Monika
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2015, (05): : 28 - 39
  • [32] The 5-HT1A receptor in Major Depressive Disorder
    Kaufman, Joshua
    DeLorenzo, Christine
    Choudhury, Sunia
    Parsey, Ramin V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (03) : 397 - 410
  • [33] 5-HT1A receptor antagonists and lordosis behavior
    Uphouse, L
    Andrade, M
    CaldarolaPastuszka, M
    Jackson, A
    NEUROPHARMACOLOGY, 1996, 35 (04) : 489 - 495
  • [34] Occupancy of agonist drugs at the 5-HT1A receptor
    Bantick, RA
    Rabiner, EA
    Hirani, E
    de Vries, MH
    Hume, SP
    Grasby, PM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
  • [35] 5-HT1A Receptor and neonatal hippocampal development
    Banerjee, P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 26 - 26
  • [36] THE DESIGN OF SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS
    CLIFFE, IA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 30 - MEDI
  • [37] ANTIPEPTIDE ANTIBODIES AGAINST THE 5-HT1A RECEPTOR
    AZMITIA, EC
    YU, I
    AKBARI, HM
    KHECK, N
    WHITAKERAZMITIA, PM
    MARSHAK, DR
    JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (04) : 289 - 298
  • [38] The 5-HT1A receptor knockout mouse and anxiety
    Olivier, B
    Pattij, T
    Wood, SJ
    Oosting, R
    Sarnyai, Z
    Toth, M
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (6-7): : 439 - 450
  • [39] Regulation of agonist efficacy at the 5-HT1A receptor
    McLoughlin, DJ
    Evans, KJ
    Clarke, WP
    FASEB JOURNAL, 2001, 15 (04): : A219 - A219
  • [40] Indoloxypropanolamine analogues as 5-HT1A receptor antagonists
    Krushinski, Joseph H., Jr.
    Schaus, John M.
    Thompson, Dennis C.
    Calligaro, David O.
    Nelson, David L.
    Luecke, Susan H.
    Wainscott, David B.
    Wong, David T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (20) : 5600 - 5604
12345